New research following Spanish adults over 7 years found that higher levels of specific gut-derived fatty acids in the blood—especially butyrate and isobutyrate—were linked to an increased risk of developing type 2 diabetes, offering insights into early risk prediction.
A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months.
A randomized trial found that while both Mediterranean and low-FODMAP diets improved symptoms in patients with nonconstipated IBS, the low-FODMAP diet led to greater reductions in symptom severity.
A 92-hospital trial found that simple prompts in electronic health records helped reduce the use of broad-spectrum antibiotics in low-risk abdominal infection cases—without increasing ICU stays or length of hospitalization.
In a recent clinical trial, researchers found that a reduced-dose chemoradiotherapy regimen for early-stage anal cancer may be comparable to standard treatment in achieving short-term tumor response, while causing fewer serious side effects.
May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.